Literature DB >> 22230485

Serum levels of interleukin (IL)-18, IL-23 and IL-17 in Chinese patients with multiple sclerosis.

Ying-Chun Chen1, Sheng-Di Chen, Ling Miao, Zhen-Guo Liu, Wei Li, Zhong-Xin Zhao, Xiao-Jiang Sun, Guo-Xin Jiang, Qi Cheng.   

Abstract

It has been reported that cytokines play an important role in the pathogenesis of multiple sclerosis (MS). The aim of this study was to evaluate the serum levels of interleukin (IL)-18, IL-23 and IL-17 in Chinese patients with MS. We compared the serum concentrations of pro-inflammatory cytokines IL-18, IL-23 and IL-17 in 39 patients with MS and 39 healthy controls matched with sex and age. Serum cytokines were measured by FlowCytomix, a kind of cytometric bead-based assay. Correlations between the serum levels of the three cytokines and disability (expanded disability status scale, EDSS), disease duration, current age and age at onset were examined. Serum concentrations of all IL-18, IL-23 and IL-17 were significantly higher in MS patients than healthy controls. There were no significant differences of the three cytokines' levels between female and male healthy controls, while the serum IL-18 level was observed significantly higher (P=0.049) in male MS patients than female MS patients. No significant correlations were observed between any of the three cytokines' levels and EDSS, disease duration and current age. However, IL-23 was found negatively correlated with age at onset in male MS patients (r(s)=-0.775, P=0.041). Our data suggest that all IL-18, IL-23 and IL-17 may be involved in the pathogenesis of MS. However, the relationships of the three cytokines and clinical characteristics of MS need to be further investigated in the future.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22230485     DOI: 10.1016/j.jneuroim.2011.12.008

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  15 in total

1.  Interleukin-6 is a better metabolic biomarker than interleukin-18 in young healthy adults.

Authors:  Júlia Cristina Cardoso Carraro; Helen Hermana M Hermsdorff; Blanca Puchau; M Ángeles Zulet; Fermín I Milagro; Josefina Bressan; J Alfredo Martínez
Journal:  J Physiol Biochem       Date:  2015-02-27       Impact factor: 4.158

Review 2.  Genetic and Molecular Biology of Multiple Sclerosis Among Iranian Patients: An Overview.

Authors:  Meysam Moghbeli
Journal:  Cell Mol Neurobiol       Date:  2019-09-03       Impact factor: 5.046

Review 3.  Body fluid biomarkers in multiple sclerosis: how far we have come and how they could affect the clinic now and in the future.

Authors:  Itay Raphael; Johanna Webb; Olaf Stuve; William Haskins; Thomas Forsthuber
Journal:  Expert Rev Clin Immunol       Date:  2014-12-18       Impact factor: 4.473

4.  S100B as a Potential Biomarker and Therapeutic Target in Multiple Sclerosis.

Authors:  Andreia Barateiro; Vera Afonso; Gisela Santos; João José Cerqueira; Dora Brites; Jack van Horssen; Adelaide Fernandes
Journal:  Mol Neurobiol       Date:  2015-07-17       Impact factor: 5.590

Review 5.  How Inflammasomes Inform Adaptive Immunity.

Authors:  Charles L Evavold; Jonathan C Kagan
Journal:  J Mol Biol       Date:  2017-10-05       Impact factor: 5.469

6.  Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis Patients.

Authors:  Alessandro Trentini; Massimiliano Castellazzi; Carlo Cervellati; Maria Cristina Manfrinato; Carmine Tamborino; Stefania Hanau; Carlo Alberto Volta; Eleonora Baldi; Vladimir Kostic; Jelena Drulovic; Enrico Granieri; Franco Dallocchio; Tiziana Bellini; Irena Dujmovic; Enrico Fainardi
Journal:  Dis Markers       Date:  2016-07-31       Impact factor: 3.434

7.  Monosodium Urate Crystals Activate the Inflammasome in Primary Progressive Multiple Sclerosis.

Authors:  Federica Piancone; Marina Saresella; Ivana Marventano; Francesca La Rosa; Maria Antonia Santangelo; Domenico Caputo; Laura Mendozzi; Marco Rovaris; Mario Clerici
Journal:  Front Immunol       Date:  2018-05-04       Impact factor: 7.561

8.  Impact of Th-17 Cytokines on the Regulation of Transporters in Human Placental Explants.

Authors:  Kamelia Mirdamadi; Jacinda Kwok; Ori Nevo; Howard Berger; Micheline Piquette-Miller
Journal:  Pharmaceutics       Date:  2021-06-15       Impact factor: 6.321

9.  Differential Frequency of CD8+ T Cell Subsets in Multiple Sclerosis Patients with Various Clinical Patterns.

Authors:  Zahra Salehi; Rozita Doosti; Masoumeh Beheshti; Ehsan Janzamin; Mohammad Ali Sahraian; Maryam Izad
Journal:  PLoS One       Date:  2016-07-28       Impact factor: 3.240

10.  Inflammasome Proteins As Biomarkers of Multiple Sclerosis.

Authors:  Robert W Keane; W Dalton Dietrich; Juan Pablo de Rivero Vaccari
Journal:  Front Neurol       Date:  2018-03-19       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.